# Metabolomics Consortium Coordinating Center (M3C)

> **NIH NIH U2C** · UNIVERSITY OF FLORIDA · 2021 · $449,860

## Abstract

Metabolomics Consortium Coordinating Center Project Summary
The Metabolomics Consortium Coordinating Center (M3C) is proposed as the Stakeholder Engagement
and Program Coordinating Center (SEPCC) for stage 2 of the Common Fund Metabolomics Program of
the National Institutes of Health. The M3C will operate in conjunction with the Southeast Center for
Integrated Metabolomics (SECIM), one of six stage 1 Regional Comprehensive Metabolomics Resource
Cores (RCMRCs) founded in 2013, and now a self-supporting metabolomics service center. The
overarching goal of the M3C will be the promotion of metabolomics as a key component of biomedical
research (basic, clinical, and translational) and clinical care. The mission of the M3C is to serve as a
catalyst for the advancement of metabolomics in biomedical research and clinical care by engaging the
diverse range of stakeholders, organizing the consortium, and promoting its work. Stakeholder
engagement will include bi-annual symposia to identify roadblocks in the use of metabolomics and suggest
approaches leading to remediation. Pilot and Feasibility awards will be focused on biomedical research
projects new to the use of metabolomics. Consortium work will be organized through a web portal
providing access to all consortium resources, including access to datasets in the National Metabolomics
Data Repository, and tools developed by the Metabolomics Data Analysis and Interpretation Tools
awardees. M3C further organizes the work of the consortium by facilitating on-line and in-person meetings
of governance groups and workgroups. M3C promotes the work of the consortium through social media,
its web portal, presentations at scientific meetings, and distribution of consortium standards, policies,
procedures, protocols, best practices, and guidelines. M3C develops a strategic plan for the consortium,
generates metrics regarding the activities of the consortium, participates in evaluation, and creates the
consortium annual report. The work of the coordinating center, and of the stage 2 metabolomics
consortium, will lead to improved human health through basic research findings, improved laboratory
practices, and translation to clinical research and care.

## Key facts

- **NIH application ID:** 10197917
- **Project number:** 5U2CDK119889-04
- **Recipient organization:** UNIVERSITY OF FLORIDA
- **Principal Investigator:** Michael Conlon
- **Activity code:** U2C (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $449,860
- **Award type:** 5
- **Project period:** 2018-08-17 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10197917

## Citation

> US National Institutes of Health, RePORTER application 10197917, Metabolomics Consortium Coordinating Center (M3C) (5U2CDK119889-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10197917. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*